Breast Cancer Survivors Clinical Trial
Official title:
Effectiveness of Aerobic Exercises and Laughter Yoga Compared With Yoga in Anxiety and Depression Levels of Breast Cancer Survivors; a Double-blind Three Arm Clinical Trial Study
NCT number | NCT05203029 |
Other study ID # | 55516 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | January 5, 2022 |
Est. completion date | July 29, 2022 |
Verified date | August 2022 |
Source | Isfahan University of Medical Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
90% of breast cancer survivors experience cancer-related fatigue which decreases the physical activity. Moreover, due to the cancer treatments depression and anxiety will be happened. Previous studies showed the effect of physical activity on reduction of depression and anxiety; therefore the aim of this study is to evaluate the effectiveness of aerobic exercises and laughter yoga compared with yoga in anxiety and depression levels in breast cancer survivors.
Status | Completed |
Enrollment | 198 |
Est. completion date | July 29, 2022 |
Est. primary completion date | May 20, 2022 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 20 Years to 65 Years |
Eligibility | Inclusion Criteria: - Patients aged between 20 to 65 years - Patients with stage ?-? of breast cancer - Chemotherapy is completed at least six months before registration - Lack of active participation in regular exercise programs Exclusion Criteria: - Reluctance to cooperate and enter the study - Do not complete the questionnaires correctly - Have diseases such as severe heart failure (Minnesota Living with Heart Failure Questionnaire score more than 50), severe valvular disease, coronary stenosis of the heart, and metastatic cancer - Feel chest pain and dizziness during the exercise - Patients currently receiving treatment - Patients who do not have the physical ability to participate in the exercise - Patients with mental health disorders that cannot participate in the exercise |
Country | Name | City | State |
---|---|---|---|
Iran, Islamic Republic of | Isfahan University of Medical Sciences | Isfahan |
Lead Sponsor | Collaborator |
---|---|
Isfahan University of Medical Sciences |
Iran, Islamic Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in the anxiety and depression levels after twelve weeks of exercises | Hospital anxiety and depression scale (HADS) questionnaire will be used to determine the anxiety and depression levels. This questionnaire contains 14 questions, of which seven concern anxiety and seven concern depression. Each question is scored from 0 (never) to 3 (almost always); the final score will be 0 to 52, and the higher scores indicate greater anxiety and depression. | 0 and 3 months | |
Secondary | Changes in the general quality of life after twelve weeks of exercises | 36-item short form survey (SF-36) questionnaire will be used to determine the quality of life. This questionnaire comprises 36 items and eight domains, including limitations in physical activities because of health problems, limitations in social activities because of physical or emotional issues, limitations in usual role activities because of physical health problems, bodily pain, general mental health (psychological distress and well-being), limitations in usual role activities because of emotional problems, vitality (energy and fatigue), and general health perceptions. Each question is scored from 0 to 100; the final score is the average score from 0 to 100, and the higher scores show a better quality of life. The scores will be reported for each domain separately | 0 and 3 months | |
Secondary | Changes in the disease-specific quality of life after twelve weeks of exercises | Minnesota Living with Heart Failure Questionnaire (MLHFQ) will be used to determine the disease-specific quality of life. It has 21 items in physical, emotional and socioeconomic dimensions; each item scored from 0 to 5 provides a total score between 0 to 105: the higher the score, the lower quality of life. | 0 and 3 months | |
Secondary | Changes in the Insomnia severity after twelve weeks of exercises | The Insomnia Severity Index questionnaire will be used to determine the insomnia severity. It has seven questions; each item has a score from 0 to 4. The seven answers are added up to get a total score from 0 to 28. The higher scores represent severe insomnia. | 0 and 3 months | |
Secondary | Changes in depression after twelve weeks of exercises | Beck's depression inventory-? (BDI-?) will be used to measure depression. This questionnaire has 21 questions scored from 0 to 3. The total score will calculate by adding up all the scores-the higher scores indicating the higher depression. | 0 and 3 months | |
Secondary | Changes in chronic fatigue after twelve weeks of exercises | Chalder's chronic fatigue syndrome questionnaire will be utilized to measure chronic fatigue. This questionnaire has 14 items, eight items are about physical symptoms, and six other items are about mental symptoms. Each question scored between 0 to 3, and the total score will be 0 to 42. The higher the score, the more suffer from fatigue. | 0 and 3 months | |
Secondary | Changes in mindfulness after twelve weeks of exercises | Mindfulness will be measured by five facet mindfulness questionnaire (FFMQ). It has 39 questions in five domains: observation, description, aware actions, non-judgmental inner experience, and non-reactivity. Each question scored between 1 to 5, and the total score will be in the range of 39 to 195. The higher score shows the higher mindfulness. | 0 and 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04049695 -
Improving Cognition After Cancer
|
N/A | |
Completed |
NCT03696056 -
Improving Brain Function After Breast Cancer Study
|
N/A | |
Recruiting |
NCT06073717 -
Motor-cognitive Training Effects on Cognition in Breast Cancer Survivors: the BRAINonFIT Study (BRAINonFIT).
|
N/A | |
Active, not recruiting |
NCT00981305 -
Impact of Lactate-Containing Vaginal Lubricant on Sexual Dysfunction in Young Breast Cancer Survivors
|
Phase 3 | |
Active, not recruiting |
NCT03674437 -
Evaluation of an Online, Remote Cognitive Battery for Use in Cancer Survivorship
|
||
Active, not recruiting |
NCT05743023 -
Consciousness-based Ayurveda Lifestyle Program for Improving Quality of Life in Survivors of Breast Cancer
|
N/A | |
Completed |
NCT02062255 -
Impact of COX2 on Sera Biomarkers From Obese Subjects
|
Phase 0 | |
Active, not recruiting |
NCT04262180 -
Physical Activity Promotion for Breast and Endometrial Cancer Survivors
|
N/A | |
Active, not recruiting |
NCT04883398 -
A Study of Attention and Memory Processes in Breast Cancer Survivors
|
||
Completed |
NCT01217216 -
Cancer Survival Through Weight Loss and Exercise
|
N/A | |
Completed |
NCT05506189 -
Life Style Modification for Breast Canccer Survivors Using Mobile App-based Human Coaching Program
|
||
Recruiting |
NCT03644329 -
Effect of Resistance Training Variable Manipulation in Postmenopausal Breast Cancer Survivors.
|
N/A | |
Active, not recruiting |
NCT02726763 -
Feasibility and Tolerability of Transcranial Direct Current Stimulation With Concurrent Cognitive Training
|
N/A | |
Completed |
NCT05690295 -
Resistance-type Exercise Training in Postmenopausal Women Survivors of Breast Cancer
|
N/A | |
Recruiting |
NCT06334354 -
A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)
|
||
Recruiting |
NCT03394690 -
Effects of Green Coffee Extract Supplementation on Leptin, Ghrelin, Adiponectin,Anthropometric Measurements, Lipid Profile in Breast Cancer Survivors
|
N/A | |
Completed |
NCT02753985 -
Adherence to Aromatase Inhibitors: The Role of Partners
|
||
Active, not recruiting |
NCT04818359 -
Movement and Health Beyond Care (MoviS)
|
N/A | |
Recruiting |
NCT05848141 -
Rowing Following Breast Cancer Chemotherapy
|
N/A | |
Completed |
NCT02672189 -
Internet-based Cognitive Behavioral Therapy for Breast Cancer Patients With Climacteric Symptoms
|
Phase 3 |